2019 AIChE Annual Meeting

Session: Continuous Drug Substance Isolation

Continuous manufacturing has significant advantages in terms of increased selectivity, safety, throughput, and quality compared to batch processing. Industry, academia, and regulatory agencies have been carrying out extensive research on utilization of continuous technologies in drug substance manufacturing. This session will focus on applications and advances made by continuous processing relating to isolation technologies applied to the production of drug substances. The session encourages talks elaborating on experimental and modeling approaches for continuous crystallization, extraction, and isolation.

Chair

Andy Bommarius, Georgia Institute of Technology

Co-Chair

David A. Acevedo, U.S. Food and Drug Administration

Presentations

12:30 PM

Ronald Rousseau, Matthew McDonald, Martha Grover, Andy Bommarius

12:51 PM

Joseph Imbrogno, Steven M. Guinness, Rajesh Kumar, Andrew Derrick, Emma McInturff, Mark Guinn

01:12 PM

Isabella Aigner, Manuel Zettl, Manuel Kreimer, Thomas Mannschott, Peter van der Wel, Johannes G. Khinast, Markus Krumme, Theresa R. Hörmann

01:54 PM

Ebenezer Ojo, Humera Siddique, Ian Houson, Ruairi O'Meadhra, Ali Anwar, Berthold Schenkel, Alastair Florence

02:15 PM

Xiaochuan Yang, David A. Acevedo, Sean Naimi, Sonal Mazumder, Thomas O'Connor, Celia Cruz, Jiaxiang Zhang, Jiahao Wu

02:36 PM

David A. Acevedo, Xiaochuan Yang, Jiaxiang Zhang, Sonal Mazumder, Thomas O'Connor, Rapti Madurawe, Celia Cruz